BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06764875-completion@plaintrial.com
DTSTAMP:20261027T144610Z
DTSTART;VALUE=DATE:20301209
SUMMARY:A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimi
 dine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-posit
 ive Gastric Cancer — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06764875
URL:https://plaintrial.com/trial/NCT06764875
END:VEVENT
END:VCALENDAR